Amgen

Amgen and The Economist Intelligence Unit (EIU) today released a comprehensive new report entitled, “The Cost of Silence: Cardiovascular disease in Asia.” The report, which was developed by EIU and sponsored by Amgen, estimates that in the eight Asian economies studied, US$53bn of the total costs of primary ischaemic heart disease (IHD) and stroke are attributable to four modifiable risk factors: smoking, hypertension, obesity and high cholesterol.